 |
OSI
Pharmaceuticals Provides Update on Diabetes and Obesity Clinical
Programs |
| |
Phase I clinical trial data showed positive
evidence of clinical activity, and are now progressing to the next
stage of clinical development. PSN821 completed a single dose Phase
I trial in healthy volunteers and diabetes patients, where evidence
of glucose lowering was seen in response to a standard nutrient
challenge (PharmaLive) |
| |
|
|
Evaluation
of Urolithiasis: A Link between Stone Formation and Diabetes
Mellitus? |
| |
In Germany, patients with DM are at higher risk
of UL compared with patients without diabetes. We demonstrated
a significantly higher prevalence of urinary stones in patients
with coronary heart disease. These findings are consistent with
the hypothesis that urinary stone formation has a vascular pathogenesis
in part (Urologia Internationalis) |
| |
|
|
Nonstop
Insulin Improves Vascular Surgery Outcome |
| |
Continuous perioperative insulin infusion reduces
the incidence of major cardiovascular events in patients who undergo
vascular surgery, researchers report (Medscape) |
| |
|
